Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Matinas BioPharma Holdings, Inc. | 3,539,416 | reported | 08 Sept 2017 | tx 1+5,000 |
| Vallon Pharmaceuticals, Inc. | 23,605 | reported | 18 Sept 2025 | tx 5+98,906 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Sept 2025 | GRANT_AWARD | Vallon Pharmaceuticals, Inc. | 23,605 | 0.00 USD | deriv |
| 26 Aug 2025 | GRANT_AWARD | Vallon Pharmaceuticals, Inc. | 5,994 | 0.00 USD | deriv |
| 13 Aug 2025 | GRANT_AWARD | Vallon Pharmaceuticals, Inc. | 4,527 | 0.00 USD | deriv |
| 23 Jan 2025 | GRANT_AWARD | Vallon Pharmaceuticals, Inc. | 30,297 | 0.69 USD | deriv |
| 10 Aug 2023 | GRANT_AWARD | Vallon Pharmaceuticals, Inc. | 34,483 | 2.90 USD | deriv |
| 08 Sept 2017 | PURCHASE | Matinas BioPharma Holdings, Inc. | 5,000 | 1.36 USD |